|
HHS Biomedical Advanced Research and Development Authority (BARDA) Acute Radiation Syndrome Dosimetry Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
Interagency Working Group established under BARDA that determines dosimetry requirements for radiological and nuclear contingencies
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/ Nuclear Integrated Program Team
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
Interagency Working Group established under BARDA that determines overall radiation countermeasures strategy and priorities.
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/Nuclear Working Group on Blood and Tissue Products
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
Working group coordinates requirements, needs, and R&D directions for blood and tissue products for mass casualty treatment after a radiation emergency
|
|
HHS Biovigilance Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, OS
|
CC, NHLBI
|
Develop systems for reporting adverse events resulting from blood transfusion or donation.
|
|
HHS Blood Safety Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NHLBI
|
The committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood safety including, public health parameters related to the safety and availability of blood and blood products; broad public health, ethical and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood safety and availability.
|
|
HHS Blood, Organ, and Tissue Safety Committee (BOTSEC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, OS
|
CC, NHLBI
|
Advises Asst. Secretary on issues related to blood safety and availability and scientific and policy issues regarding blood safety and organ transplantation.
|
|
HHS Data Council
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIA, NIMH
|
Coordinates all health and human services data collection and analysis activities of the Department of Health and Human Services, including an integrated data collection strategy, coordination of health data standards and health and human services and privacy policy activities.
|
|
HHS Dietary Guidance Review Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AoA, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
This committee reviews draft nutrition materials developed by all federal agencies and fulfills the legislative mandate (1990 NNMRRA) to ensure that federal dietary guidance is consistent with the Dietary Guidelines for Americans and is scientifically accurate.
|
|
HHS Federal Partners Sickle Cell Disease Initiative
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI
|
The partnership seeks to enhance coordination and collaboration across HHS agencies to improve the care of people with sickle cell disease by enhancing data on patient populations, facilitating reliable access to quality care and services, fostering innovative new drug development, and conducting biomedical and behavior research.
|
|
HHS Health Literacy Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NEI, NCI, NLM, OD
|
This Workgroup is comprised of various HHS agencies that work towards meeting the Department’s prevention goals and to accomplish the Healthy People 2010 Objective: Improve the health literacy of persons with inadequate or marginal literacy skills
|